Overview
- 28 inspections across 28 sites are on record.
- 38 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-12-15.
At a glance
Inspections
28
Sites
28
Observations
38
Career since
Jan 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Argenta US Manufacturing LLC | 15 Dec 2023 | Human Drugs | View 483 → |
| Patheon Biologics LLC | 10 Nov 2023 | Human Drugs | On file |
| Steris Corporation | 6 Nov 2023 | Human Drugs | On file |
| Respirent Pharmaceuticals Co., Ltd. | 18 Aug 2023 | Human Drugs | |
| Henan Dongtai Pharm Co., Ltd. | 11 Aug 2023 | Human Drugs |
Sites inspected
Argenta US Manufacturing LLCShawnee, United States1 insp.
Patheon Biologics LLCSaint Louis, United States1 insp.
Steris CorporationSaint Louis, United States1 insp.
Respirent Pharmaceuticals Co., Ltd.Chongqing, China1 insp.
Henan Dongtai Pharm Co., Ltd.Anyang, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Gretchen L Trendel4 shared
Lisa L Flores4 shared
Robert J Ham3 shared
Anastasia M Shields3 shared
Monica E Murie2 shared
Megan T Ziegler1 shared
Hamet M Toure1 shared
Janete F Guardia1 shared
Michael Shanks1 shared
Michael C Zubelewicz1 shared
Full investigator report
Get the verbatim findings behind Jill J Tillman's 38 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site